has been cited by the following article(s):
[1]
|
A review of criteria strictness in “Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials”
Vaccine,
2023
DOI:10.1016/j.vaccine.2023.07.072
|
|
|
[2]
|
Late Onset of Injection Site Reactions After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Adult Study Populations
Human Vaccines & Immunotherapeutics,
2018
DOI:10.1080/21645515.2018.1452576
|
|
|
[3]
|
Pneumococcal Conjugate Vaccine Safety in Elderly Adults
Open Forum Infectious Diseases,
2018
DOI:10.1093/ofid/ofy100
|
|
|
[4]
|
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
New England Journal of Medicine,
2015
DOI:10.1056/NEJMoa1408544
|
|
|
[5]
|
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
Human Vaccines & Immunotherapeutics,
2015
DOI:10.1080/21645515.2015.1030550
|
|
|
[6]
|
13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
Drugs,
2015
DOI:10.1007/s40265-015-0449-z
|
|
|
[7]
|
Pneumococcal conjugate vaccine use in adults
Expert Review of Vaccines,
2015
DOI:10.1586/14760584.2016.1132171
|
|
|